UNSPSC 51314348: Chlorpheniramine/phenylephrine/phenylpropanolamine/pyrilamine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE501. This VA Drug Class (RE501) classifies this compound as belonging to the group ANTIHISTAMINE/DECONGESTANT.

UNSPSC 51314348 Chlorpheniramine/phenylephrine/phenylpropanolamine/pyrilamine is a Commodity code under which state and local governments procure combination antihistamine and decongestant pharmaceutical products, typically as components of broader public health, emergency response, or pharmacy benefit initiatives rather than as standalone line items. The recent solicitation activity shows state health agencies and county public health departments buying these products as part of larger pharmaceutical supply agreements, emergency preparedness programs, and multi-state cooperative purchasing vehicles. Issuing bodies include state departments of health and human services, county public health offices, and cooperative purchasing alliances that aggregate demand across multiple state and local jurisdictions. The work spans supply chain setup for direct-to-manufacturer prescription programs, competitive procurement of generic and OTC pharmaceuticals through authorized wholesalers, and emergency drug procurement for community health initiatives.

Recent opportunities include Seminole County, Florida's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building; the Texas Health and Human Services Commission's RFI HHS0017013 (posted April 3, 2026) exploring direct-to-manufacturer prescription fulfillment capabilities for the state's pharmacy benefit program; and the Minnesota Multistate Cooperative Purchasing Alliance's RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) establishing multiple contracts for generic multi-source pharmaceuticals and OTC products distributed across Minnesota, Oregon, and other participating jurisdictions through AmerisourceBergen, Cardinal Health, and Morris & Dickson. Geographic activity spans Florida, Texas, Minnesota, and Oregon through cooperative purchasing networks. Vendors pursuing this code should note that recent procurements emphasize cGMP compliance, Drug Supply Chain Security Act certification, fixed pricing structures, EDI capability, and contractual relationships with established pharmaceutical wholesalers.